The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.497
https://www.valueinhealthjournal.com/article/S1098-3015(13)02402-9/fulltext
Title :
The Cost-Effectiveness of Bendamustine Versus Fludarabine for the First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02402-9&doi=10.1016/j.jval.2013.08.497
First page :
A409
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
479